// ESR1

Development of mass spectrometric methods combined with chemometrics in a non-target approach for identification of hitherto unknown PFASs.

// ESR3

Determining the release of legacy, alternative and unknown PFASs to the atmosphere and consequences for near- and far-field human exposure.

// ESR4

Development of analytical methods for determination of new known (e.g. PFECA, PFESA, HFPO-dimer and trimer acids, polyfluorinated acids) and unknown PFASs.

// ESR5

Using in vitro human skin equivalent models to characterize the trans-dermal uptake of PFASs from both indoor dust and source materials .

// ESR6

Investigating the impact of legacy and emerging PFAS, as well as human-relevant PFAS mixtures on cholesterol homeostasis and cholesterol synthesis and metabolism.

// ESR7

Development of cell- and organ-on-chip-based metabolomic and lipidomic approaches using human adrenal cortex.

// ESR8

Development and application of methods for assessing legacy and alternative PFASs using the total oxidizable precirsr method in addition to total fluorine concentrations in human plasma.

// ESR9

Assessment of the effects of legacy and replacement PFAS exposure on gene expression and diabetes.

// ESR10

To identify associations between available PFAS concentration data in human serum and corresponding serum lipids and metabolomics data.

// ESR11

Evaluation of innovative treatment techniques for the decomposition and removal of PFASs in stormwater, groundwater, wastewater and landfill leachate.

// ESR12

Development of an innovative technique for in-situ remediation of PFASs contaminated groundwater.

// ESR13

Determining the fate and transport behaviour of PFAS in diverse natural unsaturated soils with and without sorbent amendments.

// ESR14

Biodegradation assays of newly synthesized PFASs and potential PFASs precursors in closed bottle systems, analysis of degradation products.

// ESR15

Determine if fluorinated and non-fluorinated alternatives are safer, more sustainable alternatives to long-chain PFASs in selected consumer products and to propose options for the assessment, regulation and management of alternative PFASs where necessary.